Research graph
References from Pandemic-Related Reductions in Respiratory Infections and New-Onset Nephrotic Syndrome: A Multicenter Cohort Study in Japan. Local targets link to admitted publications; unresolved targets remain external evidence.
Minimal change disease
10.2215/cjn.05000516 · 2017 · External reference
Idiopathic nephrotic syndrome in children
10.1016/s0140-6736(18)30536-1 · 2018 · External reference
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
10.1007/s00467-024-06634-9 · 2025 · External reference
Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis
10.1186/s13052-015-0123-9 · 2015 · External reference
Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome
10.1007/s00467-006-0316-y · 2007 · External reference
Bronchiolitis in COVID-19 times: a nearly absent disease?
10.1007/s00431-021-03968-6 · 2021 · External reference
Impact of COVID-19 control measures on influenza positivity among patients with acute respiratory infections, 2018-2023: an interrupted time series analysis
10.1186/s12879-025-11279-6 · 2025 · External reference
Impact of COVID-19 on respiratory virus infections in children, Japan, 2018-2023
10.1002/iid3.70176 · 2025 · External reference
Collateral impact of COVID-19: why should children continue to suffer?
10.1007/s00431-021-03963-x · 2021 · External reference
Consequences of coronavirus disease-2019 (COVID-19) lockdown on infection-related hospitalizations among the pediatric population in Denmark
10.1007/s00431-021-03934-2 · 2021 · External reference
Incidence of idiopathic nephrotic syndrome during the Covid-19 pandemic in the Paris area (France) and in the Netherlands
10.1007/s00467-023-06006-9 · 2023 · External reference
Rates of idiopathic childhood nephrotic syndrome relapse are lower during the COVID-19 pandemic
10.1007/s00467-022-05483-8 · 2022 · External reference
Compliance trajectory and patterns of COVID-19 preventive measures, Japan, 2020-2022
10.3201/eid2909.221754 · 2023 · External reference
CORoNaWork project. Association between COVID-19 infection rates by region and implementation of non-pharmaceutical interventions: a cross-sectional study in Japan
10.1093/pubmed/fdab385 · 2023 · External reference
KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children
10.1016/j.kint.2024.11.007 · 2025 · External reference
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
10.1007/s00467-022-05739-3 · 2023 · External reference
Relapse rate in children with nephrotic syndrome during the SARS-CoV-2 pandemic
10.1007/s00467-022-05702-2 · 2023 · External reference
Incidence and relapse triggers of childhood idiopathic nephrotic syndrome between 2006 and 2016: a population-based study in Fukushima, Japan
10.1620/tjem.253.125 · 2021 · External reference
The impact of COVID-19 lockdown on infectious diseases epidemiology: the experience of a tertiary Italian Pediatric Emergency Department
10.1016/j.ajem.2021.01.065 · 2021 · External reference
10.1016/s2589-7500(21)00077-7
10.1016/s2589-7500(21)00077-7 · 2021 · External reference
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
10.1681/asn.2006070710 · 2007 · External reference
Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood
10.1016/j.isci.2022.104694 · 2022 · External reference
Molecular mechanisms of proteinuria in minimal change disease
2021 · External reference
Impact of COVID-19 on paediatric care in Japan: analysis of national health insurance claims data
10.1111/apa.17533 · 2025 · External reference
Patient attendance at a pediatric emergency referral hospital in an area with low COVID-19 incidence
10.1371/journal.pone.0258478 · 2021 · External reference
Delayed diagnosis and exacerbation of hyperlipidemia in idiopathic nephrotic syndrome in children during the COVID-19 pandemic
10.1007/s10157-023-02393-3 · 2023 · External reference
Epidemiology, severity, and risk of SARS-CoV-2-related relapse in children and young adults affected by idiopathic nephrotic syndrome: a retrospective observational cohort study
10.1007/s00467-022-05736-6 · 2023 · External reference
Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome
10.1007/s00467-017-3640-5 · 2017 · External reference
Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases
10.1016/j.kint.2021.05.015 · 2021 · External reference
COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area
10.1007/s00467-021-05330-2 · 2022 · External reference
Prevalence of SARS-CoV-2-IgG antibodies in children with CKD or immunosuppression
10.2215/cjn.00330121 · 2021 · External reference
